This may be due to delayed diagnoses and limited access to prostate cancer treatment options in remote areas. For these men ...

Kairos Pharma Ltd (NYSE:KAPA) saw its stock jump 165% following the announcement of encouraging safety results from its ongoing Phase 2 clinical trial of ENV-105 in patients battling metastatic ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

Investing.com -- Kairos Pharma Ltd (NYSE: KAPA) stock surged 165% after the clinical-stage biopharmaceutical company reported positive safety results from its ongoing Phase 2 clinical trial of ENV-105 ...

Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces positive safety results from its ongoing Phase 2 ...

Former Sky News presenter Dermot Murnaghan has said he “fell through the gaps” and had a “wake-up call” after receiving his ...

Stage four prostate cancer can mean that the cancer has spread into different parts of the body including nearby body organs, ...

The broadcaster, 67, announced his diagnosis with stage four prostate cancer in June, saying he was ‘responding positively’ to treatment.

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of these men will die of causes ...

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

Kenya’s fight against cancer has entered a new phase, driven by technological breakthroughs that promise to transform diagnosis, treatment, and survival rates.

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...